Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Serum metallothionein in newly diagnosed patients with childhood solid tumours.

Krizkova S, Masarik M, Majzlik P, Kukacka J, Kruseova J, Adam V, Prusa R, Eckschlager T, Stiborova M, Kizek R.

Acta Biochim Pol. 2010;57(4):561-6. Epub 2010 Nov 9.

2.

Use of brightness wavelet transformation for automated analysis of serum metallothioneins- and zinc-containing proteins by Western blots to subclassify childhood solid tumours.

Vyslouzilova L, Krizkova S, Anyz J, Hynek D, Hrabeta J, Kruseova J, Eckschlager T, Adam V, Stepankova O, Kizek R.

Electrophoresis. 2013 Jun;34(11):1637-48. doi: 10.1002/elps.201200561. Epub 2013 Apr 26.

PMID:
23417248
3.

Soluble p185(HER-2) in patients with malignant bone tumours.

Holzer G, Pfandlsteiner T, Koschat M, Noske H, Trieb K, Kotz R.

Pediatr Blood Cancer. 2005 Feb;44(2):163-6.

PMID:
15468309
4.

Serum levels of TNF-beta and sTNF-R in patients with malignant bone tumours.

Holzer G, Pfandlsteiner T, Blahovec H, Trieb K, Kotz R.

Anticancer Res. 2003 May-Jun;23(3C):3057-9.

PMID:
12926161
5.

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.

Holzer G, Obermair A, Koschat M, Preyer O, Kotz R, Trieb K.

Med Pediatr Oncol. 2001 Jun;36(6):601-4.

PMID:
11344490
6.

Are serum levels of CD44 relevant in children with pediatric sarcomas?

Kebudi R, Ayan I, Yasasever V, Demokan S, Görgün O.

Pediatr Blood Cancer. 2006 Jan;46(1):62-5.

PMID:
16155927
7.

Serum metallothioneins in childhood tumours-a potential prognostic marker.

Kruseova J, Hynek D, Adam V, Kizek R, Prusa R, Hrabeta J, Eckschlager T.

Int J Mol Sci. 2013 Jun 6;14(6):12170-85. doi: 10.3390/ijms140612170.

8.

Role of 99mTc-hexakis-2-methoxyisobutylisonitrile for detecting marrow metastases in childhood solid tumours.

Berberoğlu K, Unal SN, Kebudi R, Türkmen C, Cantez S.

Nucl Med Commun. 2005 Dec;26(12):1075-80.

PMID:
16264353
9.

Round cell tumors in childhood: the application of newer techniques to the differential diagnosis.

Triche TJ.

Perspect Pediatr Pathol. 1982;7:279-322. No abstract available.

PMID:
6956846
10.

Diagnostic value of cytologic specimens obtained from children with cancer.

Helson L, Krochmal P, Hajdu SI.

Ann Clin Lab Sci. 1975 Jul-Aug;5(4):294-7.

PMID:
169727
11.

Serum intercellular adhesion molecule-1 in childhood malignancy.

Pui CH, Luo X, Evans W, Martin S, Rugg A, Wilimas J, Crist WM, Hudson M.

Blood. 1993 Aug 1;82(3):895-8.

12.

Interval between symptom onset and diagnosis of pediatric solid tumors.

Pollock BH, Krischer JP, Vietti TJ.

J Pediatr. 1991 Nov;119(5):725-32.

PMID:
1941378
13.

[Blood serum somatomedin activity in children with bone tumors].

Vasil'eva IA, Ionov AA, Borodina AF.

Vopr Onkol. 1982;28(7):38-41. Russian.

PMID:
6954761
14.

A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family.

Riley RD, Burchill SA, Abrams KR, Heney D, Sutton AJ, Jones DR, Lambert PC, Young B, Wailoo AJ, Lewis IJ.

Eur J Cancer. 2003 Jan;39(1):19-30. Review.

PMID:
12504654
15.

Using of chicken antibodies for metallothionein detection in human blood serum and cadmium-treated tumour cell lines after dot- and electroblotting.

Krizkova S, Adam V, Eckschlager T, Kizek R.

Electrophoresis. 2009 Nov;30(21):3726-35. doi: 10.1002/elps.200900201.

PMID:
19862750
16.

Immunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumours.

Fuentealba IC, Mullins JE.

Histol Histopathol. 1999 Jan;14(1):51-61.

PMID:
9987650
17.

Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.

Rutkowski P, Kamińska J, Kowalska M, Ruka W, Steffen J.

J Surg Oncol. 2003 Nov;84(3):151-9.

PMID:
14598359
18.

Osteosarcoma and Ewing's sarcoma in children and adolescents: retrospective clinicopathological study.

Ilić I, Manojlović S, Cepulić M, Orlić D, Seiwerth S.

Croat Med J. 2004 Dec;45(6):740-5.

19.

Correlation of metallothionein expression with clinical progression of cancer in the oral cavity.

Szelachowska J, Dziegiel P, Jelen-Krzeszewska J, Jelen M, Tarkowski R, Spytkowska B, Matkowski R, Kornafel J.

Anticancer Res. 2009 Feb;29(2):589-95.

Supplemental Content

Support Center